Key Metrics of Marcus Corporation
Revenue$730M▲ 7.7% YoYFY 2023
Operating income$33.9M▲ 308.5% YoY
Net profit$14.8M▲ 223.6% YoY
Shareholders' equity$471M
Market cap$871MMCS · $28.26
Competitors10identified
About Marcus Corporation
Sectors
Company details
- Website
- marcuscorp.com
- Listed
- NYSE: MCS
Operational Areas of Marcus Corporation
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameThe Marcus Corporation
TickerMCS
ExchangeNYSE
CountryUnited States
SEC CIK0000062234
Listed since—
IndustryMovies/Entertainment
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttp://www.marcuscorp.com
US market & SEC filings
MCS · NYSE · SEC CIK 0000062234
Last price · 29 Oct 2026
$28.26
+1.40%
Market cap$871M
P/E—On FY 2023 diluted EPS
Volume102,514
SectorConsumer DiscretionaryMovies/Entertainment
Country · IPOUnited States
MCS share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeMilwaukee
GSTIN—
Email—
Websitehttp://www.marcuscorp.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Marcus Corporation
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Business activities and related parties
hospitality industry
Filings
No filings on record yet.